Literature DB >> 22875457

FGF23: instability may affect accuracy and interpretation.

E R Smith, L P McMahon, S G Holt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22875457     DOI： 10.1007/s00198-012-2036-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN： 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  7 in total

1.  Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).

Authors:  P Manghat; I Souleimanova; J Cheung; A S Wierzbicki; D J Harrington; M J Shearer; P Chowienczyk; P Chowiencki; I Fogelman; M Nerlander; D Goldsmith; G Hampson
Journal:  Bone       Date:  2011-01-31       Impact factor: 4.398

2.  FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart.

Authors:  Martin L Ford; Edward R Smith; Laurie A Tomlinson; Prabal K Chatterjee; Chakravarthi Rajkumar; Stephen G Holt
Journal:  Nephrol Dial Transplant       Date:  2011-07-12       Impact factor: 5.992

3.  FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.

Authors:  L Desjardins; S Liabeuf; C Renard; A Lenglet; H-D Lemke; G Choukroun; T B Drueke; Z A Massy
Journal:  Osteoporos Int       Date:  2011-11-23       Impact factor: 4.507

4.  Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies.

Authors:  Edward R Smith; Martin L Ford; Laurie A Tomlinson; Gary Weaving; Bernard F Rocks; Chakravarthi Rajkumar; Stephen G Holt
Journal:  Clin Chim Acta       Date:  2011-02-12       Impact factor: 3.786

5.  Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.

Authors:  P Manghat; W D Fraser; A S Wierzbicki; I Fogelman; D J Goldsmith; G Hampson
Journal:  Osteoporos Int       Date:  2009-12-09       Impact factor: 4.507

6.  Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.

Authors:  Orlando M Gutiérrez; Michael Mannstadt; Tamara Isakova; Jose Alejandro Rauh-Hain; Hector Tamez; Anand Shah; Kelsey Smith; Hang Lee; Ravi Thadhani; Harald Jüppner; Myles Wolf
Journal:  N Engl J Med       Date:  2008-08-07       Impact factor: 91.245

7.  Evaluation of human fibroblast growth factor 23 (FGF-23) C-terminal and intact enzyme-linked immunosorbent-assays in end-stage renal disease patients.

Authors:  W J Fassbender; V Brandenburg; S Schmitz; D Sandig; S A Simon; J Windolf; U C Stumpf
Journal:  Clin Lab       Date:  2009       Impact factor: 1.138
  7 in total
  1 in total

1.  Lack of predictive value of FGF23 levels on pulse wave velocity.

Authors:  L Desjardins; S Liabeuf; Z A Massy
Journal:  Osteoporos Int       Date:  2012-08-09       Impact factor: 4.507
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.